APO Research
Talk to an analyst

APO RESEARCH · REPORT

Somatostatin Analogs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Somatostatin Analogs Industry Growth and Trends Forecast to 2032

22 December 202579 pages

Choose your research edition.

Industry ResearchSomatostatin Analogs Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Somatostatin Analogs Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Somatostatin Analogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Somatostatin Analogs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Somatostatin Analogs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Somatostatin Analogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Somatostatin Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Somatostatin Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Somatostatin Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Somatostatin Analogs include Novartis, Peptron, Ipsen Biopharmaceutical and Chiasma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Somatostatin Analogs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Somatostatin Analogs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Somatostatin Analogs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Somatostatin Analogs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Somatostatin Analogs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Somatostatin Analogs Market by Company

Novartis

Peptron

Ipsen Biopharmaceutical

Chiasma

Somatostatin Analogs Segment by Type

Pasireotide

Lanreotide

Octreotide

Somatostatin Analogs Segment by Application

Acromegaly

Neuroendocrine Tumor

Cushing Syndrome

Carcinoid Syndrome

Others

Somatostatin Analogs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin Analogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Somatostatin Analogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin Analogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Somatostatin Analogs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Somatostatin Analogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pasireotide Table 2. Major Company of Lanreotide Table 3. Major Company of Octreotide Table 4. Global Somatostatin Analogs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Somatostatin Analogs Sales by Type (2021-2026) & (k units) Table 6. Global Somatostatin Analogs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Somatostatin Analogs Sales Market Share in Value by Type (2021-2026) Table 9. Global Somatostatin Analogs Price by Type (2021-2026) & (US$/unit) Table 10. Global Somatostatin Analogs Sales by Type (2027-2032) & (k units) Table 11. Global Somatostatin Analogs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Somatostatin Analogs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Somatostatin Analogs Sales Market Share in Value by Type (2027-2032) Table 14. Global Somatostatin Analogs Price by Type (2027-2032) & (US$/unit) Table 15. North America Somatostatin Analogs Sales by Type (2021-2026) & (k units) Table 16. North America Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Somatostatin Analogs Sales by Type (2021-2026) & (k units) Table 18. Europe Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Somatostatin Analogs Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Somatostatin Analogs Sales by Type (2021-2026) & (k units) Table 22. Latin America Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Somatostatin Analogs Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 25. Somatostatin Analogs Industry Trends Table 26. Somatostatin Analogs Industry Drivers Table 27. Somatostatin Analogs Industry Opportunities and Challenges Table 28. Somatostatin Analogs Industry Restraints Table 29. Global Somatostatin Analogs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Somatostatin Analogs Revenue Market Share by Company (2021-2026) Table 31. Global Somatostatin Analogs Sales by Company (2021-2026) & (k units) Table 32. Global Somatostatin Analogs Sales Share by Company (2021-2026) Table 33. Global Somatostatin Analogs Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Somatostatin Analogs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Somatostatin Analogs Major Company Production Sites and Headquarters Table 36. Global Somatostatin Analogs Company, Product Type & Application Table 37. Global Somatostatin Analogs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Somatostatin Analogs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Somatostatin Analogs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Somatostatin Analogs Sales by Region (2021-2026) & (k units) Table 42. Global Somatostatin Analogs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Somatostatin Analogs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Somatostatin Analogs Sales Market Share in Value by Region (2021-2026) Table 45. Global Somatostatin Analogs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Somatostatin Analogs Sales by Region (2027-2032) & (k units) Table 47. Global Somatostatin Analogs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Somatostatin Analogs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Somatostatin Analogs Sales Market Share in Value by Region (2027-2032) Table 50. Global Somatostatin Analogs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Somatostatin Analogs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Somatostatin Analogs Sales by Application (2021-2026) & (k units) Table 53. Global Somatostatin Analogs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Somatostatin Analogs Sales Market Share in Value by Application (2021-2026) Table 56. Global Somatostatin Analogs Price by Application (2021-2026) & (US$/unit) Table 57. Global Somatostatin Analogs Sales by Application (2027-2032) & (k units) Table 58. Global Somatostatin Analogs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Somatostatin Analogs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Somatostatin Analogs Sales Market Share in Value by Application (2027-2032) Table 61. Global Somatostatin Analogs Price by Application (2027-2032) & (US$/unit) Table 62. North America Somatostatin Analogs Sales by Application (2021-2026) & (k units) Table 63. North America Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Somatostatin Analogs Sales by Application (2021-2026) & (k units) Table 65. Europe Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Somatostatin Analogs Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Somatostatin Analogs Sales by Application (2021-2026) & (k units) Table 69. Latin America Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Somatostatin Analogs Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Somatostatin Analogs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Novartis Somatostatin Analogs Product Portfolio Table 76. Novartis Recent Development Table 77. Peptron Company Information Table 78. Peptron Business Overview Table 79. Peptron Somatostatin Analogs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Peptron Somatostatin Analogs Product Portfolio Table 81. Peptron Recent Development Table 82. Ipsen Biopharmaceutical Company Information Table 83. Ipsen Biopharmaceutical Business Overview Table 84. Ipsen Biopharmaceutical Somatostatin Analogs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Ipsen Biopharmaceutical Somatostatin Analogs Product Portfolio Table 86. Ipsen Biopharmaceutical Recent Development Table 87. Chiasma Company Information Table 88. Chiasma Business Overview Table 89. Chiasma Somatostatin Analogs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Chiasma Somatostatin Analogs Product Portfolio Table 91. Chiasma Recent Development Table 92. North America Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 93. North America Somatostatin Analogs Sales by Country (2021-2026) & (k units) Table 94. North America Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 95. North America Somatostatin Analogs Sales Forecast by Country (2027-2032) & (k units) Table 96. North America Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 97. North America Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Somatostatin Analogs Market Share by Country (2021-2026) Table 100. North America Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 102. Europe Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 103. Europe Somatostatin Analogs Sales by Country (2021-2026) & (k units) Table 104. Europe Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 105. Europe Somatostatin Analogs Sales Forecast by Country (2027-2032) & (k units) Table 106. Europe Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Somatostatin Analogs Market Share by Country (2021-2026) Table 110. Europe Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Somatostatin Analogs Sales by Country (2021-2026) & (k units) Table 114. Asia-Pacific Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Somatostatin Analogs Sales Forecast by Country (2027-2032) & (k units) Table 116. Asia-Pacific Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Somatostatin Analogs Market Share by Country (2021-2026) Table 120. Asia-Pacific Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 122. Latin America Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. Latin America Somatostatin Analogs Sales by Country (2021-2026) & (k units) Table 124. Latin America Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 125. Latin America Somatostatin Analogs Sales Forecast by Country (2027-2032) & (k units) Table 126. Latin America Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Somatostatin Analogs Market Share by Country (2021-2026) Table 130. Latin America Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Somatostatin Analogs Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Somatostatin Analogs Sales Forecast by Country (2027-2032) & (k units) Table 136. Middle East and Africa Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Somatostatin Analogs Market Share by Country (2021-2026) Table 140. Middle East and Africa Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Somatostatin Analogs Distributors List Table 145. Somatostatin Analogs Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Somatostatin Analogs Image Figure 2. Global Somatostatin Analogs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Somatostatin Analogs Market Size (2021-2032) & (US$ Million) Figure 4. Global Somatostatin Analogs Sales (2021-2032) & (k units) Figure 5. Pasireotide Image Figure 6. Global Pasireotide Sales YoY Growth (2021-2032) & (k units) Figure 7. Lanreotide Image Figure 8. Global Lanreotide Sales YoY Growth (2021-2032) & (k units) Figure 9. Octreotide Image Figure 10. Global Octreotide Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Somatostatin Analogs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Somatostatin Analogs Market Share by Type 2025 VS 2032 Figure 13. North America Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 14. North America Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 15. Europe Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Somatostatin Analogs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Acromegaly Image Figure 26. Global Acromegaly Sales YoY Growth (2021-2032) & (k units) Figure 27. Neuroendocrine Tumor Image Figure 28. Global Neuroendocrine Tumor Sales YoY Growth (2021-2032) & (k units) Figure 29. Cushing Syndrome Image Figure 30. Global Cushing Syndrome Sales YoY Growth (2021-2032) & (k units) Figure 31. Carcinoid Syndrome Image Figure 32. Global Carcinoid Syndrome Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Somatostatin Analogs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Somatostatin Analogs Market Share by Application 2025 VS 2032 Figure 37. North America Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 38. North America Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 39. Europe Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 47. North America Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Somatostatin Analogs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Somatostatin Analogs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Pasireotide
  • Lanreotide
  • Octreotide
Applications
  • Acromegaly
  • Neuroendocrine Tumor
  • Cushing Syndrome
  • Carcinoid Syndrome
  • Others
Companies covered
  • Novartis
  • Peptron
  • Ipsen Biopharmaceutical
  • Chiasma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Somatostatin Analogs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Somatostatin Analogs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Somatostatin Analogs Market by Type
  6. 1.3.1 Pasireotide
  7. 1.3.2 Lanreotide
  8. 1.3.3 Octreotide
  9. 1.4 Global Somatostatin Analogs Market Size by Type
  10. 1.4.1 Global Somatostatin Analogs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Somatostatin Analogs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Somatostatin Analogs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Somatostatin Analogs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Somatostatin Analogs Industry Trends
  2. 2.2 Somatostatin Analogs Industry Drivers
  3. 2.3 Somatostatin Analogs Industry Opportunities and Challenges
  4. 2.4 Somatostatin Analogs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Somatostatin Analogs Revenue (2021-2026)
  2. 3.2 Global Top Players by Somatostatin Analogs Sales (2021-2026)
  3. 3.3 Global Top Players by Somatostatin Analogs Price (2021-2026)
  4. 3.4 Global Somatostatin Analogs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Somatostatin Analogs Major Company Production Sites & Headquarters
  6. 3.6 Global Somatostatin Analogs Company, Product Type & Application
  7. 3.7 Global Somatostatin Analogs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Somatostatin Analogs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Somatostatin Analogs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Somatostatin Analogs Tier 1, Tier 2, and Tier 3
4 Somatostatin Analogs Regional Status and Outlook
  1. 4.1 Global Somatostatin Analogs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Somatostatin Analogs Historic Market Size by Region
  3. 4.2.1 Global Somatostatin Analogs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Somatostatin Analogs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Somatostatin Analogs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Somatostatin Analogs Forecasted Market Size by Region
  7. 4.3.1 Global Somatostatin Analogs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Somatostatin Analogs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Somatostatin Analogs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Somatostatin Analogs by Application
  1. 5.1 Somatostatin Analogs Market by Application
  2. 5.1.1 Acromegaly
  3. 5.1.2 Neuroendocrine Tumor
  4. 5.1.3 Cushing Syndrome
  5. 5.1.4 Carcinoid Syndrome
  6. 5.1.5 Others
  7. 5.2 Global Somatostatin Analogs Market Size by Application
  8. 5.2.1 Global Somatostatin Analogs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Somatostatin Analogs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Somatostatin Analogs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Somatostatin Analogs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Somatostatin Analogs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Peptron
  8. 6.2.1 Peptron Company Information
  9. 6.2.2 Peptron Business Overview
  10. 6.2.3 Peptron Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Peptron Somatostatin Analogs Product Portfolio
  12. 6.2.5 Peptron Recent Developments
  13. 6.3 Ipsen Biopharmaceutical
  14. 6.3.1 Ipsen Biopharmaceutical Company Information
  15. 6.3.2 Ipsen Biopharmaceutical Business Overview
  16. 6.3.3 Ipsen Biopharmaceutical Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ipsen Biopharmaceutical Somatostatin Analogs Product Portfolio
  18. 6.3.5 Ipsen Biopharmaceutical Recent Developments
  19. 6.4 Chiasma
  20. 6.4.1 Chiasma Company Information
  21. 6.4.2 Chiasma Business Overview
  22. 6.4.3 Chiasma Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chiasma Somatostatin Analogs Product Portfolio
  24. 6.4.5 Chiasma Recent Developments
7 North America by Country
  1. 7.1 North America Somatostatin Analogs Sales by Country
  2. 7.1.1 North America Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Somatostatin Analogs Sales by Country (2021-2026)
  4. 7.1.3 North America Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Somatostatin Analogs Market Size by Country
  6. 7.2.1 North America Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Somatostatin Analogs Market Size by Country (2021-2026)
  8. 7.2.3 North America Somatostatin Analogs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Somatostatin Analogs Sales by Country
  2. 8.1.1 Europe Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Somatostatin Analogs Sales by Country (2021-2026)
  4. 8.1.3 Europe Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Somatostatin Analogs Market Size by Country
  6. 8.2.1 Europe Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Somatostatin Analogs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Somatostatin Analogs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Somatostatin Analogs Sales by Country
  2. 9.1.1 Asia-Pacific Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Somatostatin Analogs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Somatostatin Analogs Market Size by Country
  6. 9.2.1 Asia-Pacific Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Somatostatin Analogs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Somatostatin Analogs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Somatostatin Analogs Sales by Country
  2. 10.1.1 South America Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Somatostatin Analogs Sales by Country (2021-2026)
  4. 10.1.3 South America Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Somatostatin Analogs Market Size by Country
  6. 10.2.1 South America Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Somatostatin Analogs Market Size by Country (2021-2026)
  8. 10.2.3 South America Somatostatin Analogs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Somatostatin Analogs Sales by Country
  2. 11.1.1 Middle East and Africa Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Somatostatin Analogs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Somatostatin Analogs Market Size by Country
  6. 11.2.1 Middle East and Africa Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Somatostatin Analogs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Somatostatin Analogs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Somatostatin Analogs Value Chain Analysis
  2. 12.1.1 Somatostatin Analogs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Somatostatin Analogs Production Mode & Process
  7. 12.2 Somatostatin Analogs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Somatostatin Analogs Distributors
  10. 12.2.3 Somatostatin Analogs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst